- 6501. American trypanosome
- [etiologic agent of Chaga's disease in humans; vertebrate hosts include wild and domestic mammals throughout the Americas, and humans; several species of reduviid bugs are vectors. ( CSP )] (UMLS (CSP) C0041221) =Invertebrate =Trypanosoma;
| - 6551. Amifostine/Cisplatin/Monoclonal Antibody R24
- (UMLS (NCI) C0279401) =Therapeutic or Preventive Procedure
|
- 6502. American Type Culture Collection
- [A global nonprofit bioscience organization (located at 10801 University Boulevard, Manassas, VA 20110-2209 703-365-2700) that provides biological products, technical services, and educational programs to private industry, government, and academic organizations around the world. Biological products for academic and industrial labs, as well as educational and technical services. For the collection, preservation and distribution of cultures of living microorganisms, viruses, DNA probes, plants, and human and animal ( NCI )] (UMLS (HL7) C0598079) =Intellectual Product ;
=Code;
CodeSystem | - 6552. Amifostine/Cisplatin/Paclitaxel
- (UMLS (NCI) C0677679) =Therapeutic or Preventive Procedure
|
- 6503. American Water Spaniel
- [The American Water Spaniel is an active, muscular and hardy dog with a broad skull. It has a crisp-textured, tightly curled or wavy outer coat lined with a protective undercoat. Coat colors can include liver or chocolate. Height: 15-18 inches (36-46 cm.) Weight: 25-45 pounds (11-20 kg.) ( NCI )] (UMLS (NCI) C0324455) =Mammal
| - 6553. Amifostine/Cyclophosphamide
- (UMLS (NCI) C0281278) =Therapeutic or Preventive Procedure
|
- 6504. AmericanIndianAlaskaNativeLanguages
- [American Indian and Alaska Native languages currently being used in the United States. ( HL7V3.0 )] (UMLS (HL7) C1553745) =Language =CodeSystem;
=Haida;
Zu??i;
Kootenai;
Yuchi;
Plains Indian Sign Language;
Caddoan;
KiowaTanoan;
Pidgin;
EskimoAleut;
Hokan;
Iroquoian;
Muskogean;
Salishan;
UtoAztecan;
Nadene;
Penutian;
SiouanCatawba;
Wakashan;
Yukian;
Algic;
Chimakuan;
Keresan;
| - 6554. Amifostine/Cyclophosphamide/Doxorubicin/Paclitaxel
- (UMLS (NCI) C0796660) =Therapeutic or Preventive Procedure
|
- 6505. AMES mutagen test
- [ ] (UMLS (CSP) C0598910) =Laboratory Procedure; Molecular Biology Research Technique
| - 6555. Amifostine/Cyclophosphamide/Mitoxantrone/Thiotepa
- (UMLS (NCI) C0677770) =Therapeutic or Preventive Procedure
|
- 6506. Ametycine
- (UMLS (NCI) C0702050) =Organic Chemical; Antibiotic ;
| - 6556. Amifostine/Cytarabine/Idarubicin
- (UMLS (NCI) C0678038) =Therapeutic or Preventive Procedure ;
|
- 6507. AMF
- [Encoded by human GPI Gene (GPI Family), Glucose-6-Phosphate Isomerase, Neuroleukin, and Autocrine Motility Factor function in different capacities. In glycolysis and gluconeogenesis, homodimeric cytoplasmic GPI catalyzes reversible G6P and F6P isomerization. Produced by lectin-stimulated T-cells, secreted non-mitogenic NLK lymphokine acts early in antibody-secreting cell formation to induce Ig secretion. Also a neurotrophic factor for spinal and sensory neurons, NLK exhibits GPI activity. AMF is a 558-amino acid 55-kD autocrine motility polypeptide. The gene product is partly homologous to a conserved region of HTLV-III-LAV external envelope protein. Gene defects cause nonspherocytic hemolytic anemia and hydrops fetalis. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0085144) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 6557. Amifostine/Cytarabine/Mitoxantrone
- (UMLS (NCI) C0678101) =Therapeutic or Preventive Procedure
|
- 6508. AMF Receptor
- [Secreted by tumor cells, autocrine motility factor stimulates tumor motility. Its glycoprotein receptor, Autocrine Mobility Factor Receptor, has some homology to p53. In normal fibroblasts, receptor expression appears to be regulated by cell-cell contact. The level of expression is associated with the pathologic stage and grade of tumor penetration. Positive AMFR expression on tumor cells correlates with poor prognosis in bladder cancer. (from OMIM 603243 and NCI) ( NCI )] (UMLS (NCI) C0147219) =Amino Acid, Peptide, or Protein; Receptor
| - 6558. Amifostine/Cytarabine/Topotecan
- (UMLS (NCI) C0796610) ARA-C/TOPO/WR-2721 =Therapeutic or Preventive Procedure
|
- 6509. Amfetamine
- [powerful central nervous system stimulant and sympathomimetic with multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase; it is also a drug of abuse and a psychotomimetic. ( CSP )] (UMLS (NCI) C0002658) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine
| - 6559. Amifostine/Epoetin Alfa
- (UMLS (NCI) C0796335) EPO/WR-2721;
=Therapeutic or Preventive Procedure |
- 6510. AMFR
- [This gene plays a role in tumor cell motility and is associated with several carcinomas. ( NCI )] (UMLS (NCI) C1332083) AMFR Gene;
Autocrine Motility Factor Receptor Gene;
=Gene or Genome | - 6560. Amifostine/Etoposide
- (UMLS (NCI) C0796465) VP-16/WR-2721;
=Therapeutic or Preventive Procedure |
- 6511. AMG 531
- [A recombinant protein with megakarypoiesis stimulating activity. AMG 531 mimics endogenous thrombopoietin (TPO), directly binding to and activating the platelet thrombopoietin receptor (TPO-R, Mpl, or CD110 antigen), a cytokine receptor belonging to the hematopoietin receptor superfamily. Activation of TPO-R stimulates the proliferation and differentiation of megakaryocytes, resulting in an increase in the production of blood platelets. ( NCI )] (UMLS (NCI) C1505595) Amgen Megakaryopoiesis Protein 2;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance | - 6561. Amifostine/Fludarabine
- (UMLS (NCI) C0677844) =Therapeutic or Preventive Procedure ;
|
- 6512. AMH Type II Receptor
- [Encoded by human AMHR2 Gene, the 573-amino acid 62.7 kD Anti-Mullerian Hormone Receptor Type II Ser/Thr protein kinase (TGFB Receptor Family) is a type I membrane protein. Type II receptors bind ligand but require a type I receptor for signal transduction. Anti-Mullerian Hormone (AMH/MIS/MIF), produced by Sertoli cells, induces regression of Mullerian ducts, which differentiate into the uterus and fallopian tubes. Type I persistent Mullerian duct syndrome is caused by AMH gene mutation; type II syndrome is due to AMHR mutation. (OMIM, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C0380056) =Amino Acid, Peptide, or Protein; Receptor
| - 6562. Amifostine/Irinotecan
- (UMLS (NCI) C0678000) =Therapeutic or Preventive Procedure
|
- 6513. AMHR2
- [This gene plays a role in gonadal development. ( NCI )] (UMLS (NCI) C1332084) AMHR2 Gene;
Anti-Mullerian Hormone Receptor, Type II Gene;
=Gene or Genome ;
| - 6563. Amifostine/Melphalan
- (UMLS (NCI) C0281015) =Therapeutic or Preventive Procedure
|
- 6514. Amicar
- (UMLS (NCI) C0702045) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 6564. Amifostine/Mitomycin
- (UMLS (NCI) C0280865) =Therapeutic or Preventive Procedure ;
|
- 6515. amidation
- [ ] (UMLS (CSP) C0678615) =Natural Phenomenon or Process
| - 6565. Amifostine/Paclitaxel
- (UMLS (NCI) C0338346) =Therapeutic or Preventive Procedure ;
|
- 6516. amidation/deamidation
- [addition of or hydrolytic removal of an amide group. ( CSP )] (UMLS (CSP) C0872015) =Phenomenon or Process ;
=chemical reaction;
| - 6566. Amifostine/Thiotepa
- (UMLS (NCI) C0280275) =Therapeutic or Preventive Procedure
|
- 6517. amide
- [organic compound derived from ammonia by substituting an acyl radical for hydrogen, or from an acid by replacing the OH group by NH2. ( CSP )] (UMLS (CSP) C0002482) =Organic Chemical ;
| - 6567. Amifostine/Topotecan
- (UMLS (NCI) C0677737) =Therapeutic or Preventive Procedure ;
|
- 6518. amidine
- [monovalent radical or any compound containing -C(NH)-NH2. ( CSP )] (UMLS (CSP) C0002483) =Organic Chemical ;
| - 6568. AMIKACIN
- [An antibiotic drug used to treat infection. It belongs to the family of drugs called aminoglycoside antibiotics. ( NCI )] (UMLS (NCI) C0002499) =Carbohydrate; Antibiotic
|
- 6519. amidine lyase
- [These enzymes catalyze the elimination of ammonia from amidines with the formation of a double bond. EC 4.3.2. ( MSH )] (UMLS (CSP) C0524943) =Amino Acid, Peptide, or Protein; Enzyme ;
=carbon nitrogen lyase;
| - 6569. Amikacin/Ceftazidime
- (UMLS (NCI) C0280693) =Therapeutic or Preventive Procedure
|
- 6520. amidinohydrolase
- [ ] (UMLS (CSP) C0002488) =Amino Acid, Peptide, or Protein; Enzyme
| - 6570. Amikacin/Ceftriaxone
- (UMLS (NCI) C0280694) =Therapeutic or Preventive Procedure
|
- 6521. amidinotransferase
- [Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4. ( MSH )] (UMLS (CSP) C0002484) =Amino Acid, Peptide, or Protein; Enzyme
| - 6571. Amikin
- (UMLS (NCI) C0700949) =Carbohydrate; Antibiotic ;
|
- 6522. amidophosphoribosyltransferase
- [The protein encoded by this gene is a member of the purine/pyrimidine phosphoribosyltransferase family. This protein is a regulatory allosteric enzyme that catalyzes the first step of de novo purine nucleotide biosynthesis. This gene and PAICS/AIRC, a bifunctional enzyme catalyzing steps six and seven in the purine nucleotide biosynthesis pathway, are located in close proximity on chromosome 4. (from Gene) ( NCI )] (UMLS (CSP) C0002492) =Amino Acid, Peptide, or Protein; Enzyme
| - 6572. amiloride
- [pyrazine compound inhibiting sodium reabsorbtion through sodium channels in renal epithelial cells; used in conjunction with diuretics to spare potassium loss. ( CSP )] (UMLS (CSP) C0002502) =Organic Chemical; Pharmacologic Substance ;
|
- 6523. Amies transport medium
- (UMLS (HL7) C1550050) =Biomedical or Dental Material ;
=Additive/Preservative;
| - 6573. aminacrine
- [highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA; it is also used as an intracellular pH indicator. ( CSP )] (UMLS (CSP) C0002536) =Organic Chemical; Pharmacologic Substance ;
|
- 6524. Amies transport medium
- [Sodium Chloride 3.0g, Potassium Chloride 0.2g, Calcium Chloride 0.1g, Magnesium Chloride 0.1g, Monopotassium Phosphate 0.2g, Disodium Phosphate 1.15g, Sodium Thiogly collate 1.0g, Distilled Water 1 liter ( HL7V3.0 )] (UMLS (HL7) C1561454) =Intellectual Product =MaterialEntityAdditive;
| - 6574. amination
- [creation of an amine by the addition of an amino group to an organic compound or reduction of a nitro group. ( CSP )] (UMLS (CSP) C0002505) =Natural Phenomenon or Process
|
- 6525. AMIFOSTINE
- [A drug used as a chemoprotective drug to control some of the side effects of chemotherapy and radiation therapy. ( NCI )] (UMLS (NCI) C0015020) =Organophosphorus Compound; Pharmacologic Substance ;
=Organothiophosphorus Compounds;
Protective Agent =AMIFOSTINE 500 MG | - 6575. amine
- [group of compounds derived from ammonia by substituting organic radicals for the hydrogens. ( CSP )] (UMLS (CSP) C0002508) =Organic Chemical
|
- 6526. Amifostine/Azacitidine
- (UMLS (NCI) C0879480) =Therapeutic or Preventive Procedure ;
| - 6576. amine oxidase (copper)
- [A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6. ( MSH )] (UMLS (CSP) C0019587) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
|
- 6527. Amifostine/Bleomycin/Cisplatin/Etoposide
- (UMLS (NCI) C0796553) BLEO/CDDP/VP-16/WR-2721 =Therapeutic or Preventive Procedure
| - 6577. amine oxidoreductase
- [ ] (UMLS (CSP) C0002507) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 6528. Amifostine/Busulfan/Melphalan/Thiotepa
- (UMLS (NCI) C0677970) =Therapeutic or Preventive Procedure
| - 6578. amino 3 hydroxy 5 methylisoxazole 4 propionate
- [An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. ( MSH )] (UMLS (CSP) C0051318) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
|
- 6529. Amifostine/Carboplatin
- (UMLS (NCI) C0280482) =Therapeutic or Preventive Procedure ;
| - 6579. Amino Acid Biosynthesis
- [anabolic formation of aminoacids in organisms or living cells and cell extracts. ( CSP )] (UMLS (NCI) C0596074) =Molecular Function ;
=anabolism;
aminoacid metabolism |
- 6530. Amifostine/Carboplatin/Cisplatin
- (UMLS (NCI) C0280846) =Therapeutic or Preventive Procedure
| - 6580. Amino Acid Channel
- [Amino Acid Transporter proteins carry organic compounds containing an amino (-NH2) and a carboxyl (-COOH) group through solubility barriers, such as aqueous body fluids, lipid membranes or across epithelial layers. After binding substrate, transmembrane transporters often undergo an energy-dependent conformational change that moves the substrate across the membrane with (symport) or against (antiport) concentration gradients. ( NCI )] (UMLS (NCI) C0949771) Amino Acid Transporter;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 6531. Amifostine/Carboplatin/Cyclophosphamide
- (UMLS (NCI) C0677805) =Therapeutic or Preventive Procedure
| - 6581. Amino Acid Injection
- [A type of nutritional support. It is particularly useful when oral nutrition is unfeasible, impractical or inadequate. ( NCI )] (UMLS (NCI) C0280081) =Clinical Drug
|
- 6532. Amifostine/Carboplatin/Cyclophosphamide/Thiotepa
- (UMLS (NCI) C0796504) CBDCA/CTX/TSPA/WR-2721;
=Therapeutic or Preventive Procedure ;
| - 6582. Amino Acid Metabolism - Reference Pathway
- (UMLS (NCI) C1510864) Amino Acid Metabolism Pathway;
=Molecular Function ;
|
- 6533. Amifostine/Carboplatin/Epirubicin/Paclitaxel
- (UMLS (NCI) C0935734) =Therapeutic or Preventive Procedure
| - 6583. Amino Acid Receptor Binding
- [Amino Acid Receptor Interaction involves non-covalent binding through intermolecular physical forces of attraction with a group of intrinsic membrane proteins that bind to and mediate the biological effects of small organic compounds containing an amino and carboxyl group that act as neurotransmitters (e.g., glutamic acid or aspartic acid) through modification of the activity of signal transduction pathways in target cells. ( NCI )] (UMLS (NCI) C1510865) =Molecular Function ;
|
- 6534. Amifostine/Carboplatin/Etoposide/Ifosfamide
- (UMLS (NCI) C0796472) CBDCA/IFF/VP-16/WR-2721 =Therapeutic or Preventive Procedure
| - 6584. amino acid sequence
- [order of amino acids as they occur in a polypeptide chain. ( CSP )] (UMLS (NCI) C0002518) =Amino Acid Sequence
|
- 6535. Amifostine/Carboplatin/Filgrastim/Paclitaxel
- (UMLS (NCI) C0678043) =Therapeutic or Preventive Procedure ;
| - 6585. Amino Acid Synthesis Inhibition
- [Amino Acid Synthesis Inhibition involves interference with, or restraint of, enzymatic formation of organic compounds that contain an amino (-NH2) and a carboxyl (-COOH) group. ( NCI )] (UMLS (NCI) C1510866) =Physiologic Function ;
|
- 6536. Amifostine/Carboplatin/Fluorouracil/Paclitaxel
- (UMLS (NCI) C1134464) =Therapeutic or Preventive Procedure
| - 6586. Amino Acid, Peptide, or Protein
- [Amino acids and chains of amino acids connected by peptide linkages. ( NCI )] (UMLS (NCI) C1254349) =Amino Acid, Peptide, or Protein ;
|
- 6537. Amifostine/Carboplatin/Paclitaxel
- (UMLS (NCI) C0677736) =Therapeutic or Preventive Procedure ;
| - 6587. amino group
- [monovalent chemical group -NH2. ( CSP )] (UMLS (CSP) C0596072) =Inorganic Chemical ;
=chemical group;
|
- 6538. Amifostine/Carmustine/Cyclophosphamide/Cytarabine/Etoposide
- (UMLS (NCI) C0796503) ARA-C/BCNU/CTX/VP-16/WR-2721;
=Therapeutic or Preventive Procedure ;
| - 6588. AMINO-ACID TRANSPORT DIS
- (UMLS (ICD9CM) C0268641) =Disease or Syndrome
|
- 6539. Amifostine/Ciprofloxacin/Dexamethasone/Pentoxifylline
- (UMLS (NCI) C0677760) =Therapeutic or Preventive Procedure
| - 6589. Amino-Arginine
- [An amino acid derivative. As an analog of arginine, amino-arginine competes with the normal substrate arginine and binds to the heme of the NOS as a false substrate, thereby inhibiting endothelial and inducible nitric oxide synthases (eNOS / NOS III and iNOS / NOS II). Arginine is the only physiological substrate for NOS which, in eukaryotic cells, generates NO and L-citrulline from L-arginine and molecular oxygen in a five-electron transfer reaction. This clinical use of amino-arginine is limited due to its epileptogenic properties. (NCI04) ( NCI )] (UMLS (NCI) C1510863) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 6540. Amifostine/Ciprofloxacin/Pentoxifylline
- (UMLS (NCI) C0677759) =Therapeutic or Preventive Procedure
| - 6590. aminoacid analog
- [synthetic or natural compounds which resemble naturally occurring amino acids in structure and/or function. ( CSP )] (UMLS (CSP) C0178472) =Amino Acid, Peptide, or Protein =analog;
=biocytin;
phenylalanine analog;
tryptophan analog;
tyrosine analog |
- 6541. Amifostine/Cisplatin
- (UMLS (NCI) C0280662) =Therapeutic or Preventive Procedure
| - 6591. aminoacid analyzer
- [biomedical equipment or process used to determine the quantities of each individual amino acid in a protein. ( CSP )] (UMLS (CSP) C0179025) =Medical Device =Medical Devices;
|
- 6542. Amifostine/Cisplatin/Cyclophosphamide/Etoposide
- (UMLS (NCI) C0678020) =Therapeutic or Preventive Procedure
| - 6592. aminoacid inhibitor
- [any substance or state which suppresses, prevents, or opposes the action of aminoacids. ( CSP )] (UMLS (CSP) C0596075) =Pharmacologic Substance ;
=inhibitor/antagonist;
|
- 6543. Amifostine/Cisplatin/Cytarabine/Dexamethasone
- (UMLS (NCI) C0677980) =Therapeutic or Preventive Procedure
| - 6593. aminoacid metabolism
- [buildup and breakdown of aminoacids for utilization by the organism. ( CSP )] (UMLS (CSP) C0596076) =Molecular Function ;
=Intermediary Metabolism;
=Amino Acid Biosynthesis;
urea cycle |
- 6544. Amifostine/Cisplatin/Docetaxel
- (UMLS (NCI) C0879412) =Therapeutic or Preventive Procedure
| - 6594. aminoacid oxidase
- [ ] (UMLS (CSP) C0596077) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
|
- 6545. Amifostine/Cisplatin/Etoposide
- (UMLS (NCI) C0280936) =Therapeutic or Preventive Procedure
| - 6595. aminoacid sequence of peptide
- [ ] (UMLS (CSP) C0920679) aminoacid sequence of protein;
peptide sequence =Amino Acid Sequence ;
|
- 6546. Amifostine/Cisplatin/Fluorouracil
- (UMLS (NCI) C0677739) =Therapeutic or Preventive Procedure ;
| - 6596. aminoacid transport
- [movement of aminoacids through a biological system at the cellular level; can be across cell membranes and epithelial layers and also can occur within intracellular compartments and extracellular compartments. ( CSP )] (UMLS (CSP) C0596078) =Cell Function ;
=biological transport;
|
- 6547. Amifostine/Cisplatin/Fluorouracil/Paclitaxel
- (UMLS (NCI) C0796643) =Therapeutic or Preventive Procedure
| - 6597. aminoacid tRNA ligase
- [A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS. ( MSH )] (UMLS (CSP) C0002529) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 6548. Amifostine/Cisplatin/Gemcitabine
- (UMLS (NCI) C0677827) =Therapeutic or Preventive Procedure ;
| - 6598. aminoacyl fatty acid
- [ ] (UMLS (CSP) C0598431) =Lipid ;
|
- 6549. Amifostine/Cisplatin/Interleukin-2
- (UMLS (NCI) C0280272) =Therapeutic or Preventive Procedure
| - 6599. aminoacyl nucleotide
- [ ] (UMLS (CSP) C0598999) =Nucleic Acid, Nucleoside, or Nucleotide ;
|
- 6550. Amifostine/Cisplatin/Irinotecan
- (UMLS (NCI) C0879428) =Therapeutic or Preventive Procedure
| - 6600. aminoacyl tRNA
- [intermediates in protein biosynthesis; the compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase; they are key compounds in the genetic translation process. ( CSP )] (UMLS (CSP) C0035714) =Nucleic Acid, Nucleoside, or Nucleotide; Amino Acid, Peptide, or Protein; Biologically Active Substance =transfer RNA;
|
home 
Armenian-English 
top